1192782
Cooper Institute for Advanced Reproductive Medicine — FEI 3011006339
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 9, 2022
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Houston, TX (United States)
Citations
| ID | CFR | Description |
| 12213 | 21 CFR 1271.47(a) | Testing, screening, donor eligibility procedures |
| 12250 | 21 CFR 1271.55(d)(4) | Ten year retention |
| 12277 | 21 CFR 1271.75(a)(1) | Risk factors, clinical evidence |
| 12492 | 21 CFR 1271.85(a) | Infection with communicable disease agents |
| 12496 | 21 CFR 1271.85(b)(2) | SOP for release; reactive for CMV |